vs
Side-by-side financial comparison of Eightco Holdings Inc. (ORBS) and SS Innovations International, Inc. (SSII). Click either name above to swap in a different company.
SS Innovations International, Inc. is the larger business by last-quarter revenue ($14.5M vs $10.2M, roughly 1.4× Eightco Holdings Inc.). SS Innovations International, Inc. runs the higher net margin — -17.0% vs -2281.6%, a 2264.6% gap on every dollar of revenue. On growth, SS Innovations International, Inc. posted the faster year-over-year revenue change (79.1% vs -49.9%). SS Innovations International, Inc. produced more free cash flow last quarter ($-3.2M vs $-11.0M). Over the past eight quarters, SS Innovations International, Inc.'s revenue compounded faster (99.9% CAGR vs 13.1%).
SS Innovations International, Inc. is a global medical technology enterprise specializing in the research, development and manufacturing of innovative surgical robotic systems. It provides high-precision, accessible robotic platforms for minimally invasive surgery, catering to healthcare facilities across multiple regions to boost surgical outcomes and cut procedural burdens.
ORBS vs SSII — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $10.2M | $14.5M |
| Net Profit | $-232.5M | $-2.5M |
| Gross Margin | -13.0% | 43.9% |
| Operating Margin | -475.0% | -3.7% |
| Net Margin | -2281.6% | -17.0% |
| Revenue YoY | -49.9% | 79.1% |
| Net Profit YoY | -9183.3% | -28.5% |
| EPS (diluted) | $-2.34 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $10.2M | $14.5M | ||
| Q3 25 | $5.3M | $12.8M | ||
| Q2 25 | $7.6M | $10.0M | ||
| Q1 25 | $9.9M | $5.1M | ||
| Q4 24 | $20.3M | $8.1M | ||
| Q3 24 | $6.1M | $4.4M | ||
| Q2 24 | $5.3M | $4.5M | ||
| Q1 24 | $8.0M | $3.6M |
| Q4 25 | $-232.5M | $-2.5M | ||
| Q3 25 | $-25.8M | $-3.7M | ||
| Q2 25 | $-1.2M | $-256.7K | ||
| Q1 25 | $-2.5M | $-5.7M | ||
| Q4 24 | $-2.5M | $-1.9M | ||
| Q3 24 | $-3.2M | $-3.2M | ||
| Q2 24 | $4.4M | $-4.1M | ||
| Q1 24 | $1.9M | $-9.8M |
| Q4 25 | -13.0% | 43.9% | ||
| Q3 25 | -3.7% | 48.1% | ||
| Q2 25 | 16.4% | 59.1% | ||
| Q1 25 | 8.2% | 21.2% | ||
| Q4 24 | 8.2% | 48.9% | ||
| Q3 24 | 26.5% | 52.8% | ||
| Q2 24 | 25.1% | 31.9% | ||
| Q1 24 | 17.5% | 20.0% |
| Q4 25 | -475.0% | -3.7% | ||
| Q3 25 | -116.9% | -14.3% | ||
| Q2 25 | -15.9% | 1.0% | ||
| Q1 25 | -14.3% | -115.6% | ||
| Q4 24 | -11.9% | -22.7% | ||
| Q3 24 | -29.1% | -73.1% | ||
| Q2 24 | -16.4% | -90.9% | ||
| Q1 24 | -39.6% | -270.3% |
| Q4 25 | -2281.6% | -17.0% | ||
| Q3 25 | -487.6% | -29.0% | ||
| Q2 25 | -15.4% | -2.6% | ||
| Q1 25 | -25.7% | -111.0% | ||
| Q4 24 | -12.3% | -23.7% | ||
| Q3 24 | -52.5% | -74.0% | ||
| Q2 24 | 84.2% | -91.8% | ||
| Q1 24 | 24.4% | -270.5% |
| Q4 25 | $-2.34 | $-0.01 | ||
| Q3 25 | $-0.58 | $-0.02 | ||
| Q2 25 | $-0.38 | $0.00 | ||
| Q1 25 | $-0.84 | $-0.03 | ||
| Q4 24 | $-1.44 | $-0.01 | ||
| Q3 24 | $-1.77 | $-0.02 | ||
| Q2 24 | $2.15 | $-0.02 | ||
| Q1 24 | $1.42 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $58.5M | $3.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $232.6M | $38.2M |
| Total Assets | $250.2M | $74.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $58.5M | $3.2M | ||
| Q3 25 | $23.7M | $5.7M | ||
| Q2 25 | $696.3K | $11.4M | ||
| Q1 25 | $434.4K | $15.9M | ||
| Q4 24 | $239.2K | $466.5K | ||
| Q3 24 | $2.4M | $220.4K | ||
| Q2 24 | $363.1K | $608.2K | ||
| Q1 24 | $808.8K | $948.1K |
| Q4 25 | $232.6M | $38.2M | ||
| Q3 25 | $339.2M | $39.6M | ||
| Q2 25 | $8.9M | $42.0M | ||
| Q1 25 | $9.7M | $40.6M | ||
| Q4 24 | $11.9M | $13.5M | ||
| Q3 24 | $13.0M | $13.7M | ||
| Q2 24 | $13.8M | $14.8M | ||
| Q1 24 | $3.9M | $16.7M |
| Q4 25 | $250.2M | $74.2M | ||
| Q3 25 | $355.5M | $69.6M | ||
| Q2 25 | $48.7M | $70.0M | ||
| Q1 25 | $47.6M | $63.5M | ||
| Q4 24 | $50.8M | $42.4M | ||
| Q3 24 | $49.2M | $39.0M | ||
| Q2 24 | $48.4M | $35.7M | ||
| Q1 24 | $50.2M | $35.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.0M | $-1.5M |
| Free Cash FlowOCF − Capex | $-11.0M | $-3.2M |
| FCF MarginFCF / Revenue | -107.7% | -22.3% |
| Capex IntensityCapex / Revenue | 0.0% | 11.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-22.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.0M | $-1.5M | ||
| Q3 25 | $-1.6M | $-7.5M | ||
| Q2 25 | $-659.2K | $-3.5M | ||
| Q1 25 | $999.8K | $-6.1M | ||
| Q4 24 | $-6.6M | $-3.3M | ||
| Q3 24 | $77.7K | $-2.5M | ||
| Q2 24 | $-440.3K | $-1.0M | ||
| Q1 24 | $-723.3K | $-2.7M |
| Q4 25 | $-11.0M | $-3.2M | ||
| Q3 25 | — | $-8.2M | ||
| Q2 25 | $-661.3K | $-3.8M | ||
| Q1 25 | $999.7K | $-7.0M | ||
| Q4 24 | $-6.6M | $-3.4M | ||
| Q3 24 | $73.0K | $-4.2M | ||
| Q2 24 | — | $-3.1M | ||
| Q1 24 | — | $-2.8M |
| Q4 25 | -107.7% | -22.3% | ||
| Q3 25 | — | -64.1% | ||
| Q2 25 | -8.7% | -37.7% | ||
| Q1 25 | 10.1% | -136.2% | ||
| Q4 24 | -32.7% | -41.7% | ||
| Q3 24 | 1.2% | -96.9% | ||
| Q2 24 | — | -69.5% | ||
| Q1 24 | — | -76.9% |
| Q4 25 | 0.0% | 11.8% | ||
| Q3 25 | 0.0% | 5.9% | ||
| Q2 25 | 0.0% | 3.2% | ||
| Q1 25 | 0.0% | 17.0% | ||
| Q4 24 | 0.0% | 1.5% | ||
| Q3 24 | 0.1% | 38.8% | ||
| Q2 24 | — | 46.8% | ||
| Q1 24 | — | 3.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.10× | — | ||
| Q1 24 | -0.37× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ORBS
Segment breakdown not available.
SSII
| System Sales | $13.4M | 92% |
| Other | $1.2M | 8% |
